← Back to Influence Map
Entity DossierOrganization
SANOFI US SERVICES INC
DC · US
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$7,340,000
Connections
13
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MANManufacturing
$9.2MHCRHealth Issues
$9.2MMMMMedicare/Medicaid
$9.2MTRDTrade
$9.2MTAXTaxation/Internal Revenue Code
$9.2MCPTCopyright/Patent/Trademark
$9.2MTORTOR
$1.9MBills Referenced in Lobbying Filings
insulinmarch-inPBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0157: Medicare Program: Alternative Payment Model Updates and the Increasing Organ Transplant Access Model | Source |
| Employed by | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Employed by | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In Rights | Source |
| Employed by | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby on Pharmaceuticals | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,860,000 | Source |
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,540,000 | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,160,000 | Source |
| Lobbied for | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,540,000 | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Employed by | CHECKMATE GOVERNMENT RELATIONS | Hired CHECKMATE GOVERNMENT RELATIONS to lobby on Pharmaceuticals | Source |
| Lobbied for | Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Lobbied for | Rights to Federally Funded Inventions and Licensing of Government Owned Inventions | Lobbied on march-in — matched LDA filing topic to Federal Register rule. | Source |
| Parent of | SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) | Genzyme is a subsidiary of Sanofi, acquired in 2011 | Source |